In this study, we demonstrated that rMV-SLAMblind can infect and kill lung cancer cells, by targeting Nectin-4, in particular NSCLC cells, both in vitro and in vivo resulting in cell death and tumor regression. This evidence concerns the gene NECTIN4 and lung carcinoma.